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Cancer is a serious societal health problem, which can affect each of us, and its incidence 
increases rapidly with age. Anthracycline antibiotics (ANT) are extremely effective drugs that 
have been used to treat a number of cancers. They have a multimodal mechanism of action, one 
of them being the inhibition of topoisomerase 2 (TOP2), an essential cellular enzyme 
modulating DNA topology. Currently, use of ANTs is limited due to concerns about the 
occurrence of cardiotoxicity.  
 
Etoposide (ETO) is an antitumor agent that acts as topoisomerase poison. ETO is often 
used in combination therapy with ANTs, but it is not considered significantly cardiotoxic. 
Dexrazoxane (DEX) is the only approved cardioprotectant against cardiotoxicity of ANTs. 
However, it does not act as chelating agent, as previously thought, but through inhibition of 
TOP2. Although DEX has been shown to be a very potent cardioprotectant, it also has its 
disadvantages. DEX has been associated with the occurrence of secondary malignancies.   
 
The aim of the study was to determine whether other inhibitors of TOP2, namely (BNS-
22, XK-469, ICRF-193) affect antiproliferative effect of ETO on the HL-60 leukemic cell line. 
For the tested agents, concentrations corresponding with their IC50 were determined and on the 
basis of this concentration their antiproliferative effects were evaluated both alone and in 
combination with ETO. For determination of cell viability, MTT assay was used. According to 
our results none of the tested substances significantly reduced the antitumor effect of ETO on 
HL-60 cells. On the contrary, ICRF-187 and ICRF-193 in combination with ETO showed  
a synergistic effect. BNS-22 and XK-469 also showed synergistic effect, but only in 
concentration around the IC50, in other concentrations they seemed to be rather antagonistic.  
 
